Home Products Antibodies Biochemicals Research Areas
Service & Support Custom Services Support Promotion About Us
Sign In Sign Up

TRIP12 Rabbit pAb  (Cat.#:AYP15692)

A
小A 扫码咨询
Host: RabbitClonality: PolyclonalReactivity: Human,Mouse,RatWBIHCIF/ICC
货号 AYP15692
靶点/基因 TRIP12
宿主 Rabbit
克隆性 Polyclonal
反应种属 Human, Mouse, Rat
应用 WB, IHC, IF/ICC

Cat.#:AYP15692

SizePrice
50ul ¥1150.00 AddToCart
100ul ¥2100.00 AddToCart
  • Information

  • 应用指南

  • Immunogen

  • Target data

  • 资料与支持

  • Protocols

  • FAQs

Reactivity Human,Mouse,Rat
Host Rabbit
Clonality Polyclonal
同种型 IgG
Application WBIHCIF/ICC
Dilution WB: 1:500 - 1:1000
IHC: 1:50 - 1:100
IF/ICC: 1:50 - 1:100
Predicted MW 192kDa/220kDa/223kDa/225kDa
Observed MW 260kDa
Format Liquid
Storage Store at -20℃. Avoid freeze / thaw cycles.
Buffer: PBS with 0.02% sodium azide,50% glycerol,pH7.3.
Conjugate Unconjugated
Positive HeLa,Jurkat
Subcellular Nucleus,nucleoplasm
Purification Affinity purification

应用与推荐条件

快速判断怎么用

以下条件基于推荐浓度、验证图说明与通用实验要求整理,可作为预实验起点;不同样本和检测体系建议做梯度优化。

WB WB 推荐条件
推荐稀释 1:500 - 1:1000
建议样本/阳性对照 HeLa,Jurkat
关键条件 建议使用新鲜裂解样本,按推荐稀释比例孵育一抗,并关注理论/实测分子量
预期结果 预期信号/条带约 260kDa
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照
IHC IHC 推荐条件
推荐稀释 1:50 - 1:100
建议样本/阳性对照 HeLa,Jurkat
关键条件 石蜡切片建议优化抗原修复液 pH、修复时间和一抗孵育条件
预期结果 预期定位:Nucleus,nucleoplasm
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照
IF/ICC IF/ICC 推荐条件
推荐稀释 1:50 - 1:100
建议样本/阳性对照 HeLa,Jurkat
关键条件 建议优化固定、通透和封闭条件,并设置二抗空白对照
预期结果 预期荧光定位:Nucleus,nucleoplasm
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照

Immunogen

Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 1-240 of human TRIP12 (NP_001271143.1).
Sequence
查看序列
MSNRPNNNPGGSLRRSQRNTAGAQPQDDSIGGRSHLGQAKHKGYSPPESRKSNSKAPKVQSNTTSELSRGHLSKRSCSSSSAVIVPQPEDPDRANTSERQKTGQVPKKDNSRGVKRSASPDYNRTNSPSSAKKPKALQHTESPSETNKPHSKSKKRHLDQEQQLKSAQSPSTSKAHTRKSGATGGSRSQKRKRTESSCVKSGSGSESTGAEERSAKPTKLASKSATSAKAGCSTITDSSS

Target data

Background The protein encoded by this gene is an E3 ubiquitin-protein ligase involved in the degradation of the p19ARF/ARF isoform of CDKN2A, a tumor suppressor. The encoded protein also plays a role in the DNA damage response by regulating the stability of USP7, which regulates tumor suppressor p53.
Gene ID 9320
Gene name TRIP12
Swiss Q14669
Synonym TRIP12,TRIP-12,ULF,TRIP12 Rabbit pAb,E3 ubiquitin-protein ligase for Arf,HECT-type E3 ubiquitin transferase TRIP12,Thyroid receptor-interacting protein 12,KIAA0045
Functions E3 ubiquitin-protein ligase involved in ubiquitin fusion degradation (UFD) pathway and regulation of DNA repair. Part of the ubiquitin fusion degradation (UFD) pathway, a process that mediates ubiquitination of protein at their N-terminus, regardeless of the presence of lysine residues in target proteins. In normal cells, mediates ubiquitination and degradation of isoform p19ARF/ARF of CDKN2A, a lysine-less tumor suppressor required for p53/TP53 activation under oncogenic stress. In cancer cells, however, isoform p19ARF/ARF and TRIP12 are located in different cell compartments, preventing isoform p19ARF/ARF ubiquitination and degradation. Does not mediate ubiquitination of isoform p16-INK4a of CDKN2A. Also catalyzes ubiquitination of NAE1 and SMARCE1, leading to their degradation. Ubiquitination and degradation of target proteins is regulated by interaction with proteins such as MYC, TRADD or SMARCC1, which disrupt the interaction between TRIP12 and target proteins. Acts as a key regulator of DNA damage response by acting as a suppressor of RNF168, an E3 ubiquitin-protein ligase that promotes accumulation of 'Lys-63'-linked histone H2A and H2AX at DNA damage sites, thereby acting as a guard against excessive spreading of ubiquitinated chromatin at damaged chromosomes.
Research area

资料与技术支持

验证数据

1 张验证图

页面顶部轮播可查看应用验证图,覆盖 WB / IHC / IF/ICC。

文献引用

暂无公开文献关联,欢迎联系技术支持获取更多应用案例。

咨询案例
客户评价

暂无客户评价,使用后可提交评价与实验图片。

提交反馈
技术支持

可协助确认应用、样本、稀释比例、阳性/阴性对照和实验条件。

进入支持中心
需要确认应用条件?

请提供货号 AYP15692、实验应用、样本类型和检测体系,技术支持可协助确认稀释比例、阳性/阴性对照和 COA/批次资料。

FAQs

当前页面标注应用包括 WB, IHC, IF/ICC,建议结合页面验证图和推荐稀释比例进行预实验优化。
可通过页面询价/留言入口提交货号和批号,技术支持会协助提供对应批次资料。
页面推荐条件可作为起始浓度,不同样本、固定方式和检测体系可能需要梯度优化。

Protocols

Protocols
AYP15692